Skip to content

Factors Related to Truth Telling in Primary Caregivers

Explore Factors Related to Truth Telling in Primary Caregivers of Children Newly Diagnosed With Cancer

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02214446
Enrollment
84
Registered
2014-08-12
Start date
2014-01-31
Completion date
2014-12-31
Last updated
2014-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Caregivers of Children Newly Diagnosed With Cancer

Keywords

truth telling, hope, quality of life, care burden, children with cancer

Brief summary

The purpose in this study was to investigate the current status, changes, correlation, and predictive factors of the truth telling, hope, care burden, and quality of life during treatment in primary caregivers of newly diagnosed children with cancer.

Detailed description

Background: Over the last 50 years, telling truth in adult with cancer was direct. However, studies of truth telling in newly diagnosed children with cancer were seldom. Explore the factors and experiences related to truth telling in primary caregivers of children newly diagnosis with cancer were seldom too. Therefore, we could not estimate the current status of truth telling in primary caregivers of newly diagnosed children with cancer. Purpose: The purpose in this study was to investigate the current status, changes, correlation, and predictive factors of the truth telling, hope, care burden, and quality of life during treatment in primary caregivers of newly diagnosed children with cancer. Method: Purposive sampling structured questionnaire, used longitudinal resistance, repeated measurements, correlational design. SAS 9.3 for Windows was used for data entry and analyze. By using the frequency, percentage, mean, and standard deviation to describe demographic information and current status of truth telling. By using the mean, standard deviation, maximum and minimum to analyze hope, care burden, and quality of life. Demographic information, medical information data, truth telling, Herth Hope Index, caregiver burden scale, and quality of life index were tested by Pearson correlation coefficients; the change and predictors about truth telling, Herth Hope Index, caregiver burden scale, and quality of life index were tested by Generalized estimating equation. Limitation: Studying in one medical center in Taipei, it could not estimate the country's primary caregivers of newly diagnosed children with cancer in conclusions. Because of the limitation of the manpower, time and case numbers, study tracked only six month, could not be assessed the long-term change of the Herth Hope Index, caregiver burden scale, truth telling and quality of life in primary caregivers of newly diagnosed children with cancer.

Interventions

None listed

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Primary caregivers of children newly diagnosed with cancer must be aged 20 years or older. * Who can communicate in Chinese and Taiwanese. * Consciousness clear. * Normal cognitive function. * After the explanation, agreed to participate in the study and signed a consent form. * The age of children newly diagnosed with cancer is between 0 and 18 years old, who are newly diagnosed with cancer, before determined treatment plan. * The physician of children newly diagnosed with cancer, who were willing to participate this study and signed a consent form.

Exclusion criteria

* Primary caregivers of children newly diagnosed with cancer, who have been diagnosed mental illness. * The children were cancer recurrence. * The physician of children newly diagnosed with cancer, who were not willing to participate this study.

Design outcomes

Primary

MeasureTime frameDescription
primary caregivers' Herth Hope IndexChange from baseline at family meeting at 3 months, and at 6 monthsThe scores of primary caregivers' Herth Hope Index change from baseline at family meeting at 3 months, and at 6 months. We use Herth Hope Index(HHI) to evaluate the hope that the primary caregivers' care their child during treatment. There are twelve questions in the Herth Hope Index. The total score is from 12 to 48. Cronbach's α is .89. Retest is .80. Two weeks retest is .86. The higher the score is, the greater the hope is.
primary caregivers' quality of life indexChange from baseline at family meeting at 3 months, and at 6 monthsThe scores of primary caregivers' quality of life index change from baseline at family meeting at 3 months, and at 6 months. We use quality of life index(Q.L.I) to evaluate the quality of life that the primary caregivers' care their child during treatment. There are 66 questions in the quality of life index. The total score is from 66 to 264. Cronbach's α is .95. Two weeks retest is .87.
primary caregivers' truth tellingChange from baseline at family meeting at 3 months, and at 6 monthsThe primary caregivers' truth telling change from baseline at family meeting at 3 months, and at 6 months. Asking the primary caregivers' about that if you tell your child that he/she got the cancer, if you tell your child that he/she the treatment in future, and if you tell your child that he/she the rate of survival.
primary caregivers' care burdenChange from baseline at family meeting at 3 months, and at 6 monthsThe scores of primary caregivers' care burden change from baseline at family meeting at 3 months, and at 6 months. We use Questionnaire of care burden to evaluate the care burde that the primary caregivers' care their child during treatment. There are 20 questions in the quality of life index. The total score is from 0 to 60. Cronbach's α is .91. The higher the score is, the heavier the care burden is.

Countries

Taiwan

Contacts

Primary ContactChen-Ni Li
jatty7320@hotmail.com+886-936-806-856

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026